Trial intelligence / Profile preview

PEG bowel preparation volume comparison in hospitalized adults undergoing colonoscopy

2019-002799-15Phase 4Completed

Sponsor
Alma Mater Studiorum – Università di Bologna
Start
May 2021
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, open-label trial of polyethylene glycol + electrolytes + ascorbic acid, macrogol and Selg Esse (3 arms), sponsored by Alma Mater Studiorum – Università di Bologna. Primary endpoint: Bowel cleansing efficacy. Started May 2021; status: completed.

02

Drugs

polyethylene glycol + electrolytes + ascorbic acidmacrogolSelg Esse

Beyond the preview

Go deeper on 2019-002799-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-002799-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call